logo-loader

Destiny Pharma plc

Receive alerts
Market:
AIM
Market Cap:
£18.2 m
Price
41.50 GBX
Change
-2.35%
52 weeks high
85.00
52 weeks low
33.00

In brief

Destiny Pharma plc is a clinical stage, biotechnology company focused on the development of novel medicines that represent a new approach to the treatment of infectious disease.